1. Home
  2. APVO vs TANH Comparison

APVO vs TANH Comparison

Compare APVO & TANH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APVO
  • TANH
  • Stock Information
  • Founded
  • APVO 2016
  • TANH 2001
  • Country
  • APVO United States
  • TANH China
  • Employees
  • APVO N/A
  • TANH N/A
  • Industry
  • APVO Biotechnology: Pharmaceutical Preparations
  • TANH
  • Sector
  • APVO Health Care
  • TANH
  • Exchange
  • APVO Nasdaq
  • TANH Nasdaq
  • Market Cap
  • APVO 4.1M
  • TANH 3.5M
  • IPO Year
  • APVO N/A
  • TANH 2015
  • Fundamental
  • Price
  • APVO $3.06
  • TANH $2.04
  • Analyst Decision
  • APVO Strong Buy
  • TANH
  • Analyst Count
  • APVO 1
  • TANH 0
  • Target Price
  • APVO $5,920.00
  • TANH N/A
  • AVG Volume (30 Days)
  • APVO 191.0K
  • TANH 78.3K
  • Earning Date
  • APVO 08-07-2025
  • TANH 08-05-2025
  • Dividend Yield
  • APVO N/A
  • TANH N/A
  • EPS Growth
  • APVO N/A
  • TANH N/A
  • EPS
  • APVO N/A
  • TANH N/A
  • Revenue
  • APVO N/A
  • TANH $42,940,136.00
  • Revenue This Year
  • APVO N/A
  • TANH N/A
  • Revenue Next Year
  • APVO N/A
  • TANH N/A
  • P/E Ratio
  • APVO N/A
  • TANH N/A
  • Revenue Growth
  • APVO N/A
  • TANH N/A
  • 52 Week Low
  • APVO $2.81
  • TANH $1.45
  • 52 Week High
  • APVO $381.10
  • TANH $20.04
  • Technical
  • Relative Strength Index (RSI)
  • APVO 38.28
  • TANH 51.94
  • Support Level
  • APVO $3.01
  • TANH $2.00
  • Resistance Level
  • APVO $3.18
  • TANH $2.19
  • Average True Range (ATR)
  • APVO 0.16
  • TANH 0.15
  • MACD
  • APVO 0.19
  • TANH 0.02
  • Stochastic Oscillator
  • APVO 45.45
  • TANH 60.53

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

About TANH Tantech Holdings Ltd.

Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company through its subsidiaries is engaged in the production and distribution of household products along with a trading business which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments; the Consumer Product segment, and the Electric Vehicle (EV) segment.

Share on Social Networks: